Dr. Ross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Landsdowne St
Apt 609
Cambridge, MA 02139Phone+1 617-494-6030
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 1998 - 2001- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
Albert Einstein College of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 2005 - 2026
MT State Medical License 2002 - 2025
NY State Medical License 1997 - 2025
Publications & Presentations
PubMed
- 4 citationsEffects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1.Lucie Vu, Gerald F. Cox, Jennifer Ibrahim, M. Judith Peterschmitt, Leorah Ross
Molecular Genetics and Metabolism Reports. 2020-01-21 - 102 citationsEffect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1: The ENGAGE Randomized Clinical TrialPramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, Dominick Amato, Hagit N. Baris
JAMA. 2015-02-17 - 1 citationsHow a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendationsJeremy N. Ruskin, Catherine Ortemann-Renon, Jerome Msihid, Leorah Ross, Ana Cristina Puga
Molecular Genetics and Metabolism. 2020-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
